Ad is loading...
DFSTX
Price
$52.71
Change
+$0.90 (+1.74%)
Updated
Nov 22 closing price
VSMAX
Price
$123.45
Change
+$1.87 (+1.54%)
Updated
Nov 22 closing price
Ad is loading...

DFSTX vs VSMAX

Header iconDFSTX vs VSMAX Comparison
Open Charts DFSTX vs VSMAXBanner chart's image
DFA US Small Cap I
Price$52.71
Change+$0.90 (+1.74%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index
Price$123.45
Change+$1.87 (+1.54%)
VolumeN/A
CapitalizationN/A
DFSTX vs VSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFSTX vs. VSMAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSTX is a Buy and VSMAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 151B vs. DFSTX (17.4B). VSMAX pays higher dividends than DFSTX: VSMAX (1.42) vs DFSTX (1.08). DFSTX was incepted earlier than VSMAX: DFSTX (33 years) vs VSMAX (24 years). DFSTX is a more actively managed with annual turnover of: 20.00 vs. VSMAX (12.00). DFSTX has a lower initial minimum investment than VSMAX: DFSTX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 34.52 vs. DFSTX (31.66). VSMAX return over 5 years is better than : 63.57 vs. DFSTX (58.58).
DFSTXVSMAXDFSTX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence33 years24 years-
Gain YTD19.81821.10094%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.4B151B12%
Annual Yield % from dividends1.081.4276%
Returns for 1 year31.6634.5292%
Returns for 3 years6.5512.5652%
Returns for 5 years58.5863.5792%
Returns for 10 years72.02130.2955%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOPE166.454.32
+2.66%
Grand Canyon Education
MPWR580.818.34
+1.46%
Monolithic Power Systems
CIM14.660.04
+0.27%
Chimera Investment Corp
INKT0.68-0.01
-1.46%
MiNK Therapeutics
ME3.11-0.12
-3.72%
23andMe Holding Co